Aquatic Capital Management’s Legend Biotech LEGN Stock Holding History

Aquatic Capital Management’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$639K	Buy	35,314 +33,882	+2,366%	+$646K	0.02%	683
2025 Q4	$31.1K	Sell	1,432 -95,336	-99%	-$2.73M	﹤0.01%	1289
2025 Q3	$3.16M	Buy	+96,768	New	+$3.57M	0.06%	387
2025 Q2	–	Sell	-36,175	Closed	-$1.23M	–	1406
2025 Q1	$1.23M	Buy	+36,175	New	+$1.3M	0.03%	542
2024 Q2	–	Sell	-27,700	Closed	-$1.55M	–	1434
2024 Q1	$1.55M	Buy	27,700 +12,500	+82%	+$754K	0.05%	299
2023 Q4	$915K	Buy	15,200 +900	+6%	+$57K	0.02%	495
2023 Q3	$961K	Buy	14,300 +13,500	+1,688%	+$938K	0.04%	350
2023 Q2	$55K	Buy	+800	New	+$52.3K	﹤0.01%	973

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

FBIL

First Beijing Investment Ltd Hong Kong $2.32B AUM 8.06% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Aquatic Capital Management's LEGN Position: Q1 2026 in Review

Aquatic Capital Management increased its Legend Biotech (LEGN) stake by 2,366% in Q1 2026, buying an estimated $646K and bringing the position to 35,314 shares worth $639K. The position accounts for 0.02% of the portfolio, ranked #683.

Aquatic Capital Management first reported a position in LEGN in Q2 2023 and has held it in 8 quarters since. The position peaked at $3.16M in Q3 2025. 189 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

Aquatic Capital Management held 35,314 shares of Legend Biotech worth $639K as of Q1 2026.
Aquatic Capital Management bought 33,882 Legend Biotech shares in Q1 2026, an estimated $646K.
Legend Biotech made up 0.02% of Aquatic Capital Management's portfolio in Q1 2026, its #683 holding.
Aquatic Capital Management first reported a position in Legend Biotech in Q2 2023 and has held it in 8 quarters since.
Aquatic Capital Management's Legend Biotech position peaked at $3.16M in Q3 2025.
189 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.